Decentralized Clinical Trials (DCT)

One is very common, the other is rarely granted. Learn the key differences between waiver of consent & waiver of written consent for clinical trials

To gain a deeper understanding of eConsent, we have gathered the 10 most frequently asked questions that address the complexities of adoption, integration, and compliance measures

At DTxEast 2023, Castor joined a panel discussion to answer big questions when designing DTx clinical trials

In this blog we cover how eConsent benefits trials and aligns with IRB ethical commitments, how to prepare your IRB submission for approval, and the future impact of large language models on the informed consent process.

For successful decentralized clinical trials, researchers must encourage patient engagement. Learn 5 steps that modern companies are taking for better outcomes.

Castor is shifting the research paradigm for eCRF in clinical trials, transitioning from old, inefficient processes to a comprehensive CDMS & DCT platform.

This white paper from Castor explores the importance of choosing an EDC with an API before starting a clinical trial.

This white paper from Castor explores the importance of choosing an EDC with an API before starting a clinical trial.

Leaders from Castor discuss what changes we can expect in clinical research, technology, and data through the lens of three key pillars

Each rare disease research breakthrough offers the promise of a longer, better life for patients who otherwise may…